social media

One Less Voice on the BioBeat - Luke Timmerman Ends Stint with Xconomy

Monday mornings won’t be the same in biotech.

Luke Timmerman announced last week that he’ll no longer be writing his Monday morning BioBeat column or serving as National Biotech Editor at Xconomy.

Timmerman’s voice has stood out in our industry for consistency, optimism, pragmatism . . .  and great sports analogies.  


Source: Xconomy

The Very Angry Evolutionary Biologist


Dan Graur, PhD, Professor, University of Houston Bio and Contact Info

Listen (3:09) Study of biology overtaken by hype

Listen (4:55) Scientist vs. technician

Listen (6:34) Public unaware that all they eat are GMOs

Listen (3:58) Do you have a role as a scientist to reach out to the lay audience?

Listen (2:27) What was your reaction to gene patent decision?

Listen (1:43) Thoughts on clinical genomics

Listen (2:04) Twitter and the Very Angry Evolutionary Biologist

We're happy to welcome Dan Graur, Professor of Biology and Biochemistry at the University of Houston, back to the program. Dan and his colleagues caused a stir in the world of genetics with their publication "On the Immortality of Television Sets," a sarcastic and witty criticism of the ENCODE Project and ensuing claims about the death of "junk DNA."

In today's interview, Graur says that he's always been a critic of bad science. He sees a trend where technicians and tools folks are masquerading as scientists.

"What happened in recent years," he says, "is that we have a huge influx of people who are not versed in the basics of population genetics and molecular evolution, and such. They are all essentially people who know how to write computer programs, who believe that science is not driven by questions, but it's driven by a sort of high tech natural history--the data will tell us what is in there."

Is not biology an information science? Does not the new biologist need to be a bioinformatician as well? Graur says we do not need to reinvent the wheel when it comes to basic science. (We'll be pursuing this question in an upcoming series, "The Bioinformatician Bottleneck")

Graur is currently working on a book about GMOs for the lay audience. He also shares his thoughts on gene patents, clinical genomes, and that marvelous "time waster", Twitter.

Podcast brought to you by: See your company name here. - Promote your organization by aligning it with today's latest trends.

Pioneer in the Virtual World Announces Three New Life Science Conferences

My first LinkedIn invite was sent by a young businessman named Greg Cruikshank.  He was listed as the founder of Labroots.

Not knowing a thing at the time about social media, I wanted to understand more about this site that expected me to type in my resume and share it with the whole world.  And who was Greg Cruikshank and Labroots?

Life Science PR in the Age of Social Media with Erik Clausen, Chempetitive


Erik Clausen, Managing Partner and Vice President of Public Relations, Chempetitive Group Bio and Contact Info

Listen (6:29) PR basics still the same

Listen (6:11) Successful blogging

Listen (5:17) Personal vs. company Twitter handles

Erik Clausen has been in PR for twenty years. He's now a managing partner for Chempetitive Group, a life science PR and marketing firm. What has changed for PR professionals in today's world of Twitter, Facebook, and company blogs? What makes a company's blog successful? Are the rules of PR changing? Erik give his tips in our second show on the topic of life science PR.

Listen to the first interview with Erik on PR Tips for Scientists

The Online Conference for the Life Sciences: A Preview

Greg Cruikshank, President, BioConferenceLive Bio and Contact Info

Steve Shiflett, Technical Product Manager, Thermo Fisher Scientific Bio and Contact Info

Listen (5:10) Highlights of upcoming BCL Fall 2012

Listen (5:17) A run-down on the all new Labroots

Listen (4:15) Steve Shiflett of Thermo talks of exhibiting

For the 4th year in a row Bioconference Live has been producing virtual conferences for clinical diagnostics and the life sciences.. They put on three shows each year and this week is the Life Sciences conference Sept 12 and 13th. The conferences are free and are growing in number of speakers and audience. There’s a virtual exhibit hall where you can interact with various vendors. We have the founder of Bioconference Live, Greg Cruikshank on the line to tell us a bit about the show and then we’ll be joined by one of the participating exhibitors, Thermo.

Note: Theral will be speaking at the conference on Open Science:The People Behind the Movement on Wed at 11 am PST. Register for free.

Digital Marketing with Michael Yared, Chempetitive Group

Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. iReport/


Michael Yared, Director of Digital Strategy, Chempetitive, Bio and Contact Info

(Listen to Each Chapter or Move the Marker for Video)

Listen (3:52) What Is Digital Marketing? (Begins at 0:59)

Listen (6:56) Using LinkedIn More (Begins at 4:53)

Listen (6:31) Search Marketing and How to "Google-Proof" Your Business (Begins at 11:48)

Listen (3:32) Three Important Things to Remember with Digital Strategy (Begins at 18:20)

Listen (1:11) Were You Always the Geek? (Begins at 21:52)

Today we're in San Diego at the offices of Chempetitive Group, a marketing agency devoted to the life science industry. We're joined by Michael Yared, Director of Digital Strategy to talk about digital marketing. Michael relates the trends he sees and offers suggestions such as using a dashboard to keep track of ad statistics and how to "Google-proof" your business. In the end he offers three important things to keep in mind for your digital strategy.

Web 2.0 Comes to Lab Management: Adam Regelmann of Quartzy

- the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.


Adam Regelmann, MD, PhD, Co-Founder, Quartzy Bio and Contact Info

Listen (4:18) Freeing scientists to do science

Listen (5:58) Web 2.0 for inventory

Listen (3:53) What is the business model?

Listen (5:29) Experience at Y Combinator

Listen (1:53) From MD to entrepreneurship

Don't like how inefficient your lab is? Go out and start a new website. That's what Adam Regelmann did. With Quartzy, Adam and his co-founder, Jayant Kulkarni, have brought web 2.0 to lab inventory and order management. No more stickies. Need some supplies? Log on first to Quartzy, go to your colleagues' profiles, and check to see if those supplies could be just down the hall. Scoring a $1.2 million round of seed money last December, Adam says the site has over 8,000 scientist members. He talks with us about the circumstances which led to the site and also his experience as the first biology related company to participate in the popular Y Combinator incubator.

The Scientist's Buying Journey with Hamid Ghanadan, The Linus Group

Podcast Sponsor: Chempetitive Group - Adding "life" to life science marketing


Hamid Ghanadan, President, The Linus Group Bio and Contact Info

Listen (2:01) Genesis of the Linus Group

Listen (1:39) Dissonance between marketers and scientists?

Listen (9:41) How to market to scientists

Listen (4:23) What is content-centric marketing?

Listen (3:54) Demand generation

Listen (5:34) Company blogs- Are we all turning into journalists?

Listen (3:41) Dealing with 2012 marketing budget cuts

Listen (3:57) Pointers for using social media

Listen (2:24) New book out soon

Listen (4:03) Stereotypes of scientists

Today’s show is a must listen for anyone engaged in marketing in the life sciences. Hamid Ghanadan is President of The Linus Group, a marketing agency devoted to the life science industry. With a background in biochemistry, Hamid has created a unique company that specializes in understanding scientists and their buying behaviors. Hamid is also the editor and primary author of the Linus Report, the only publication offering critical briefings on science marketing issues.

Clinical Trials and Social Media with Craig Lipset, Pfizer

Podcast Sponsor: The Scientific Services Marketplace


Craig Lipset, Pfizer Bio and Contact Info

Bridging Listen (5:48) Bridging clinical research with eHealth

<img src="/images/speaker.jpg" alt=What happens when trial patients connect with each other online?"/> Listen (2:09) What happens when trial patients connect online?

How have patients changed Listen (4:01) How have patients changed?

What has Pfizer changed Listen (2:51) What has Pfizer changed?

Challenges with mobile health Listen (4:09) Challenges with mobile health?

How is Pfizer using social media Listen (4:58) How is Pfizer using social media?

Social media guidance Listen (9:44) Social media guidance

Pfizer and innovation Listen (1:28) Pfizer and innovation

Clinical trials in 5 years Listen (5:14) Clinical trials in 5 years

We talk with Craig Lipset of Pfizer about how social media is changing clinical trials. Craig has good support at Pfizer to launch innovative trial programs. At Pfizer he is bridging clinical research with eHealth technologies and exploring the opportunity to further inform and empower both patients and providers in the age of social media. Craig served as Vice President of Program Management at Adnexus Therapeutics and was part of the founding management team for Perceptive Informatics. He is the 2010 recipient of the DIA's Outstanding Service Award.